0000902664-23-001847.txt : 20230215 0000902664-23-001847.hdr.sgml : 20230215 20230215101120 ACCESSION NUMBER: 0000902664-23-001847 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230213 FILED AS OF DATE: 20230215 DATE AS OF CHANGE: 20230215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kepos Capital LP CENTRAL INDEX KEY: 0001512020 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40915 FILM NUMBER: 23633984 BUSINESS ADDRESS: STREET 1: 11 TIMES SQUARE, 35TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-588-7400 MAIL ADDRESS: STREET 1: 11 TIMES SQUARE, 35TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PepperLime Health Acquisition Corp CENTRAL INDEX KEY: 0001873324 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 548 MARKET STREET STREET 2: PMB 97425 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: (415) 263-9939 MAIL ADDRESS: STREET 1: 548 MARKET STREET STREET 2: PMB 97425 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 4 1 ownership.xml X0306 4 2023-02-13 1 0001873324 PepperLime Health Acquisition Corp PEPL 0001512020 Kepos Capital LP 11 TIMES SQUARE, 35TH FLOOR NEW YORK NY 10036 0 0 1 0 Class A Ordinary Shares, par value $0.0001 per share 2023-02-13 4 S 0 100000 10.1408 D 86348 I See footnote The securities to which this filing relates are held directly by certain funds (the "Kepos Funds") to which Kepos Capital LP (the "Investment Manager"), a Delaware limited partnership, serves as investment manager. Mr. Mark Carhart ("Mr. Carhart") is the managing member of Kepos Capital GP LLC, the general partner of the Investment Manager. The Investment Manager and Mr. Carhart disclaim beneficial ownership of the Issuer's securities reported herein except to the extent of its or his pecuniary interest therein, if any. Kepos Capital LP, By: /s/ Simon Raykher, General Counsel 2023-02-15 Mark Carhart, /s/ Mark Carhart 2023-02-15